Search Results - "YLA‐HERTTUALA, SEPPO"

Refine Results
  1. 1

    Angiogenic gene therapy in cardiovascular diseases: dream or vision? by Ylä-Herttuala, Seppo, Bridges, Charles, Katz, Michael G, Korpisalo, Petra

    Published in European heart journal (07-05-2017)
    “…Chronic cardiovascular diseases are significant health problems. Although current treatment strategies have tremendously improved disease management, up to 30%…”
    Get full text
    Journal Article
  2. 2

    Gene Therapy of Critical Limb Ischemia Enters Clinical Use by Ylä-Herttuala, Seppo

    Published in Molecular therapy (04-12-2019)
    “…Current treatments are based on endovascular operations and bypass surgery, but these operations are not always possible in elderly subjects. [...]there is a…”
    Get full text
    Journal Article
  3. 3

    EphrinB2/EphB4 signaling regulates non‐sprouting angiogenesis by VEGF by Groppa, Elena, Brkic, Sime, Uccelli, Andrea, Wirth, Galina, Korpisalo‐Pirinen, Petra, Filippova, Maria, Dasen, Boris, Sacchi, Veronica, Muraro, Manuele Giuseppe, Trani, Marianna, Reginato, Silvia, Gianni‐Barrera, Roberto, YläHerttuala, Seppo, Banfi, Andrea

    Published in EMBO reports (01-05-2018)
    “…Vascular endothelial growth factor (VEGF) is the master regulator of angiogenesis, whose best‐understood mechanism is sprouting. However, therapeutic VEGF…”
    Get full text
    Journal Article
  4. 4

    Biology of vascular endothelial growth factors by Roy, Himadri, Bhardwaj, Shalini, Ylä-Herttuala, Seppo

    Published in FEBS letters (22-05-2006)
    “…Angiogenesis is the process by which new blood vessels are formed from existing vessels. The vascular endothelial growth factors (VEGFs) are considered as key…”
    Get full text
    Journal Article
  5. 5

    Optimized Protocol for Accurate Titration of Adeno-Associated Virus Vectors by Suoranta, Tuisku, Laham-Karam, Nihay, Ylä-Herttuala, Seppo

    Published in Human gene therapy (01-10-2021)
    “…Adeno-associated virus (AAV) is currently the most popular gene delivery vector for gene therapy. However, variability in titration methods between different…”
    Get more information
    Journal Article
  6. 6

    Cardiac Lymphatics – A New Avenue for Therapeutics? by Vuorio, Taina, Tirronen, Annakaisa, Ylä-Herttuala, Seppo

    Published in Trends in endocrinology and metabolism (01-04-2017)
    “…Recent progress in lymphatic vessel biology and in novel imaging techniques has established the importance of the lymphatic vasculature as part of the…”
    Get full text
    Journal Article
  7. 7
  8. 8

    High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer by Sopo, Minna, Sallinen, Hanna, Hämäläinen, Kirsi, Kivelä, Annukka, Ylä-Herttuala, Seppo, Kosma, Veli-Matti, Keski-Nisula, Leea, Anttila, Maarit

    Published in PloS one (05-11-2020)
    “…Antiangiogenic therapy, although part of standard treatment in ovarian cancer, has variable efficacy. Furthermore, little is known about the prognostic…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Changes in nuclear and cytoplasmic microRNA distribution in response to hypoxic stress by Turunen, Tiia A., Roberts, Thomas C., Laitinen, Pia, Väänänen, Mari-Anna, Korhonen, Paula, Malm, Tarja, Ylä-Herttuala, Seppo, Turunen, Mikko P.

    Published in Scientific reports (17-07-2019)
    “…MicroRNAs (miRNAs) are small non-coding RNAs that have well-characterized roles in cytoplasmic gene regulation, where they act by binding to mRNA transcripts…”
    Get full text
    Journal Article
  11. 11

    Expression profiles of VEGF-A, VEGF-D and VEGFR1 are higher in distant metastases than in matched primary high grade epithelial ovarian cancer by Sopo, Minna, Anttila, Maarit, Hämäläinen, Kirsi, Kivelä, Annukka, Ylä-Herttuala, Seppo, Kosma, Veli-Matti, Keski-Nisula, Leea, Sallinen, Hanna

    Published in BMC cancer (14-06-2019)
    “…In many malignancies including ovarian cancer, different angiogenic factors have been related to poor prognosis. However, data on their relations to each other…”
    Get full text
    Journal Article
  12. 12

    Baculovirus: an Insect-derived Vector for Diverse Gene Transfer Applications by Airenne, Kari J, Hu, Yu-Chen, Kost, Thomas A, Smith, Richard H, Kotin, Robert M, Ono, Chikako, Matsuura, Yoshiharu, Wang, Shu, Ylä-Herttuala, Seppo

    Published in Molecular therapy (01-04-2013)
    “…Insect-derived baculoviruses have emerged as versatile and safe workhorses of biotechnology. Baculovirus expression vectors (BEVs) have been applied widely for…”
    Get full text
    Journal Article
  13. 13

    Functional roles of the membrane-associated AAV protein MAAP by Galibert, Lionel, Hyvönen, Amira, Eriksson, Reetta A. E., Mattola, Salla, Aho, Vesa, Salminen, Sami, Albers, Justin D., Peltola, Sanna K., Weman, Saija, Nieminen, Tiina, Ylä-Herttuala, Seppo, Lesch, Hanna P., Vihinen-Ranta, Maija, Airenne, Kari J.

    Published in Scientific reports (04-11-2021)
    “…With a limited coding capacity of 4.7 kb, adeno-associated virus (AAV) genome has evolved over-lapping genes to maximise the usage of its genome. An example is…”
    Get full text
    Journal Article
  14. 14

    Downregulation of VEGFR3 signaling alters cardiac lymphatic vessel organization and leads to a higher mortality after acute myocardial infarction by Vuorio, Taina, Ylä-Herttuala, Elias, Laakkonen, Johanna P., Laidinen, Svetlana, Liimatainen, Timo, Ylä-Herttuala, Seppo

    Published in Scientific reports (12-11-2018)
    “…Heart has a wide lymphatic network but the importance of cardiac lymphatic system in heart diseases has remained unclear. Vascular Endothelial Growth Factor…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success by Dragneva, Galina, Korpisalo, Petra, Ylä-Herttuala, Seppo

    Published in Disease models & mechanisms (01-03-2013)
    “…Angiogenic therapy, which involves the use of an exogenous stimulus to promote blood vessel growth, is an attractive approach for the treatment of ischemic…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Adenoviral Gene Therapy Vectors in Clinical Use—Basic Aspects with a Special Reference to Replication-Competent Adenovirus Formation and Its Impact on Clinical Safety by Leikas, Aleksi J., Ylä-Herttuala, Seppo, Hartikainen, Juha E. K.

    “…Adenoviral vectors are commonly used in clinical gene therapy. Apart from oncolytic adenoviruses, vector replication is highly undesired as it may pose a…”
    Get full text
    Journal Article
  19. 19

    Lymphatic Vessel Insufficiency in Hypercholesterolemic Mice Alters Lipoprotein Levels and Promotes Atherogenesis by Vuorio, Taina, Nurmi, Harri, Moulton, Karen, Kurkipuro, Jere, Robciuc, Marius R, Öhman, Miina, Heinonen, Suvi E, Samaranayake, Haritha, Heikura, Tommi, Alitalo, Kari, Ylä-Herttuala, Seppo

    “…OBJECTIVE—Lymphatic vessels collect extravasated fluid and proteins from tissues to blood circulation as well as play an essential role in lipid metabolism by…”
    Get full text
    Journal Article
  20. 20